About Aphios
Aphios is a Healthcare company based in Boston (United States) founded in 1993. Therapeutics for cancer and infectious diseases are developed. It operates in the Healthcare and Technology sectors. Aphios offers products and services including Zindol, APH-0701, nanoHYP, and Xantol. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is Aphios Pharma LLC. Its competitors include Moderna, BeiGene and Biogen; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1993 and based in Boston, United States, therapeutics are developed by the company for cancer treatment, supportive care, infectious diseases including HIV, influenza, and coronavirus, as well as central and peripheral nervous system disorders such as Alzheimers disease, multiple sclerosis, pain, and addiction. Operations focus on pharmaceutical innovation in the biotechnology sector. The lead compound, Zindol, an enhanced ginger product, targets chemotherapy-induced nausea and vomiting.
- Latest Funding Round$504.73K (USD), Grant
Sep 2024
- InvestorsCitizens Bank
& 4 more
Products & Services of Aphios
Aphios offers a comprehensive portfolio of products and services, including Zindol, APH-0701, nanoHYP, and Xantol.
Oncology treatment using nanotechnology for cancer management.
Oncology-focused drug in development pipeline.
Infectious disease treatment targeting HIV and influenza.
CNS disorder therapy for conditions like Alzheimer's.
Apps and channels of Aphios
its YouTube channel Aphios Corporation has 18 subscribers and 18 videos.
Videos from Aphios
The most watched videos on Aphios's YouTube channel, Aphios Corporation (18 subscribers). Click a video to play it here.
More on Aphios Corporation .
Funding Insights of Aphios
- Total Rounds 18
- Last Round Grant — $504,732
- First Round $109,761
(Apr 2008)
- Investors Count 5
Latest 10 of 18 funding rounds of Aphios with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $504,732 | Grant | – | – | |
| Sep 2023 | Grant | – | – | ||
| Jul 2023 | $335,700 | Grant | – | – | |
| Mar 2023 | $600,000 | Grant | – | – | |
| Apr 2020 | $15,000 | Grant | – | – | |
| Nov 2019 | Grant | – | – | ||
| Jul 2019 | $3.95M | Grant | – | – | |
| Aug 2016 | $1.09M | Grant | – | – | |
| Sep 2015 | $1.71M | Grant | – | – | |
| Jun 2014 | $224,947 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Aphios
Aphios has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Citizens Bank, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Commercial banking services are provided to individuals and businesses. | 1828 | citizensbank.com | Providence, United States | |
Research on heart, lung, blood, and sleep disorders is conducted. | nhlbi.nih.gov | Bethesda, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for Aphios
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aphios
9 people are tracked at Aphios (3 in leadership, 5 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Joseph F. Faris | Chief Financial Officer | Leadership |
Judith L. Palmer | Director of Regulatory & Clinical Affairs | Leadership |
Trevor P. Castor | President & CEO | Leadership |
Arthur D. Lander | Scientific Advisor | Board & advisors |
Jonathan Steven Alexander | Scientific Advisor | Board & advisors |
Val R. Livada | Director | Board & advisors |
Gordon M. Cragg | Scientific Advisor | Board & advisors |
Glenn T. Hong | Scientific Advisor | Board & advisors |
Catherine Prillo | Financial Controller | Team |
Complete people profiles for Aphios
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aphios
3 dated milestones of Aphios across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Aphios is founded.
- Funding First funding round of $110K.
- Funding Latest funding round, Grant, of $505K.
Competitors of Aphios
Aphios has 3 listed competitors in our database, 3 of them funded. They include Moderna, BeiGene and Biogen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. |
Detailed competitors of Aphios
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aphios
The website of Aphios (aphios.com) receives about 2.3K visits a month and ranks #6,635,872 among all websites worldwide, #6,676 in Biotechnology and Pharmaceuticals.
- Monthly visits2.3K
▲ 0.8% vs previous month
- Global rank#6,635,872
among all websites
- Category rank#6,676
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit2.0
- Average visit48 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Aphios. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pxpharma.com | pxpharma.com | 100% | – | ||
| hgsi.com | 100% | View details | |||
| ligand.com | 100% | 7K | #3,254,882 | View details | |
| serono.com | 100% | View details | |||
| shanthabiotech.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Aphios
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Aphios (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aphios
Complete news archive for Aphios
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aphios
Aphios was founded in 1993 and raised its 1st funding round 15 years after it was founded.
Aphios is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Founded in 1993 and based in Boston, United States, therapeutics are developed by the company for cancer treatment, supportive care, infectious diseases including HIV, influenza, and coronavirus, as well as central and peripheral nervous system disorders such as Alzheimers disease, multiple sclerosis, pain, and addiction. Operations focus on pharmaceutical innovation in the biotechnology sector. The lead compound, Zindol, an enhanced ginger product, targets chemotherapy-induced nausea and vomiting.
Aphios offers Zindol, APH-0701, nanoHYP, and Xantol.
Aphios has 5 investors. Key investors include Citizens Bank, NIH, HHS, SBIR, and National Heart, Lung, and Blood Institute.
Aphios operates through Aphios Pharma Llc.